Show simple item record

dc.contributor.authorHay, Elizabeth A
dc.contributor.authorCowie, Philip
dc.contributor.authorMcEwan, Andrew R
dc.contributor.authorRoss, Ruth
dc.contributor.authorPertwee, Roger G
dc.contributor.authorMacKenzie, Alasdair
dc.date.accessioned2020-01-09T15:35:01Z
dc.date.available2020-01-09T15:35:01Z
dc.date.issued2020-01
dc.identifier.citationHay , E A , Cowie , P , McEwan , A R , Ross , R , Pertwee , R G & MacKenzie , A 2020 , ' Disease associated polymorphisms within the conserved ECR1 enhancer differentially regulate the tissue specific activity of the cannabinoid‐1 receptor gene promoter; implications for cannabinoid pharmacogenetics ' , Human Mutation , vol. 41 , no. 1 , pp. 291-298 . https://doi.org/10.1002/humu.23931en
dc.identifier.issn1059-7794
dc.identifier.otherPURE: 147947182
dc.identifier.otherPURE UUID: c0735b01-0948-428b-91b8-c9411640f7d9
dc.identifier.otherPubMed: 31608546
dc.identifier.otherWOS: 000493859500001
dc.identifier.otherPubMed: 31608546
dc.identifier.otherScopus: 85074761900
dc.identifier.urihttps://hdl.handle.net/2164/13486
dc.descriptionEH was funded by Medical Research Scotland (PhD-719-2013) and GW Pharmaceuticals. AMcE was funded by BBSRC project grant (BB/N017544/1). PB and DW are funded by the Scottish Government Rural and Environment Science and Analytical Services Division to the Rowett Institute. The authors declare no conflicts of interest.en
dc.format.extent8
dc.language.isoeng
dc.relation.ispartofHuman Mutationen
dc.rights© 2019 The Authors. Human Mutation published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. https://creativecommons.org/licenses/by/4.0/en
dc.subjectDisease associated polymorphismsen
dc.subjectCannabinoid-1 receptoren
dc.subjectgene regulationen
dc.subjecttissue specificen
dc.subjectpromoteren
dc.subjectenhanceren
dc.subjectCB1 agonistsen
dc.subjecttranscription factoren
dc.subjectChromatin immunoprecipitationen
dc.subjectCannabinoid pharmacogeneticsen
dc.subjectSYSTEMen
dc.subjectcannabinoid pharmacogeneticsen
dc.subjectWin55en
dc.subjectCTCFen
dc.subjectFOSen
dc.subjectAP-1en
dc.subject212-2en
dc.subjectchromatin immunoprecipitationen
dc.subjectdisease-associated polymorphisms cannabinoid-1 receptoren
dc.subjectTRANSCRIPTIONAL REGULATIONen
dc.subjectQH426 Geneticsen
dc.subjectGenetics(clinical)en
dc.subjectGeneticsen
dc.subjectOtheren
dc.subjectPhD-719-2013en
dc.subjectBiotechnology and Biological Sciences Research Council (BBSRC)en
dc.subjectBB/N017544/1en
dc.subjectRural and Environmental Science and Analytical Services (RESAS)en
dc.subject.lccQH426en
dc.titleDisease associated polymorphisms within the conserved ECR1 enhancer differentially regulate the tissue specific activity of the cannabinoid‐1 receptor gene promoter; implications for cannabinoid pharmacogeneticsen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1002/humu.23931
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85074761900&partnerID=8YFLogxKen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record